Striatal glutamic acid decarboxylase immunoreactivity is increased after dopaminergic deafferentation: densitometric analysis.
Several lines of evidence suggest that dopamine exerts a chronic inhibitory action on GABAergic cells in the striatum, and striatal glutamic acid decarboxylase (GAD) mRNA levels are increased after ipsilateral dopaminergic denervation. In the present study we have used GAD immunocytochemistry to assess whether dopaminergic denervation results in an increase in GAD protein synthesis. In three 6-hydroxydopamine-lesioned animals, there was a perceptible increase in the density of GAD-immunoreactive (ir)staining on the side ipsilateral to the lesion. Computer-assisted densitometric analysis showed a significant increase in GAD-ir staining in the ipsilateral striatum compared to the contralateral (control) side. These data suggest that removal of striatal dopaminergic innervation results in an increase in the amount of immunoreactive GAD, the rate limiting enzyme in the synthesis of GABA.
Department of Pharmacology, Georgetown University, School of Medicine, Washington, DC.
J
J
Segovia
D M
DM
Armstrong
W C
WC
Benzing
P J
PJ
Hornby
D000344:Afferent Pathways / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects / Q000201:enzymology*; D007839:Functional Laterality; D005968:Glutamate Decarboxylase / Q000378:metabolism*; D006892:Hydroxydopamines / Q000633:toxicity; D007150:Immunohistochemistry; D008297:Male; D009928:Organ Specificity; D016627:Oxidopamine; D010296:Parietal Lobe / Q000187:drug effects / Q000201:enzymology; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D006892:Hydroxydopamines; D016627:Oxidopamine; D014446:Tyrosine 3-Monooxygenase; D005968:Glutamate Decarboxylase